Global Medical Technology Leader Selects Kneat

Rhea-AI Summary

Kneat (OTCQC: KSIOF) has secured a three-year Master Services Agreement with a global medical technology company, a division of a larger Asian manufacturer with over 30,000 employees operating in more than 160 countries. The client will implement the Kneat Gx platform for equipment validation processes.

CEO Eddie Ryan highlighted that this agreement reinforces the industry's confidence in Kneat's solutions within the life sciences sector. The company's growing platform functionality and adoption by major life sciences companies demonstrates Kneat's technical capabilities and strategic value in validation use cases.

Positive

• Secured new three-year Master Services Agreement with global medical technology company
• Client has significant global presence across 160+ countries
• Demonstrates continued adoption by major life sciences companies

Negative

• None.

LIMERICK, Ireland, Aug. 07, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a global medical technology company (“the Company”) has signed a three-year Master Services Agreement with Kneat.

The Company is a division of a larger manufacturer, headquartered in Asia, that employs over 30,000 people and provides specialty technologies and medical devices in more than 160 countries worldwide. This Company will use the Kneat Gx platform initially for equipment validation.

“This new signing again underscores the confidence in Kneat within the life sciences sector,” said Eddie Ryan, Kneat CEO. “Our software platform continues to advance with growing functionality and is designed to deliver incremental value and benefits in the years to come.”

Adoption of Kneat by the world’s largest life sciences companies, and the large-scale, multi-site deployments within them, highlight Kneat’s technical fit for the breadth of validation use cases and the strategic trust that the most demanding customers place in Kneat’s platform.

About Kneat

Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard.

Cautionary and Forward-Looking Statements

Except for the statements of historical fact contained herein, certain information presented constitutes “forward-looking information” within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat’s business development activities, the use and implementation timelines of Kneat’s software within the customer’s validation processes, the ability and intent of the customer to scale the use of Kneat’s software within the customer’s organization, and the compliance of Kneat’s platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties.

Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor’s own risk. For more information visit www.kneat.com.

For further information:

Katie Keita, Kneat Investor Relations
P: + 1 902-450-2660
E: investors@kneat.com 

FAQ

What agreement did Kneat (KSIOF) announce on August 7, 2025?

Kneat announced signing a three-year Master Services Agreement with a global medical technology company for their Kneat Gx platform, initially for equipment validation.

Who is the new client for Kneat's (KSIOF) platform?

The client is a division of a larger Asian manufacturer that employs over 30,000 people and operates in more than 160 countries, providing specialty technologies and medical devices.

What will Kneat's (KSIOF) platform be used for under this agreement?

The Kneat Gx platform will be initially used for equipment validation by the global medical technology company.

How does this agreement impact Kneat's (KSIOF) market position?

The agreement reinforces Kneat's strong position in the life sciences sector and demonstrates the platform's technical fit for validation use cases among major global companies.